[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,316
Citations 0
Invited Commentary
December 9/23, 2013

Informed Choice in Cancer Screening

Author Affiliations
  • 1Department of Medicine, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire
JAMA Intern Med. 2013;173(22):2088. doi:10.1001/jamainternmed.2013.6759

A couple of years ago one of my undergraduate students was interested in how men felt about overdiagnosis in prostate cancer screening. He surveyed 30 men who worked for Dartmouth College Facilities or the local police and fire departments. Their mean age was 50 years; half had been screened with prostate-specific antigen. Ten percent would not agree to screening if it resulted in more than 1 overtreated person per 1 cancer death adverted, and 63% would not agree to screening if it resulted in 25 or more overtreated persons per 1 death adverted.

First Page Preview View Large
First page PDF preview
First page PDF preview
×